Alcoa Inc. (NYSE: AA) reported second-quarter financial results after the markets closed on Monday. The company said that it had $0.15 in earnings per share (EPS) on $5.3 billion in revenue. Thomson Reuters had…
Talend expects to price more than 5 million American depositary shares in the range of $15 to $17 per share in an initial public offering valued up to more than $102 million.
Patheon expects to price more than 30 million shares in the range of $19 to $22 per share for a initial public offering valued up to about $771 million.
Impinj expects to price more than 4 million shares in the range of $12 to $14 per share for an initial public offering valued up to about $74 million.
Audentes Therapeutics expects to price its 5 million shares in the range of $14 to $16, for an initial public offering valued up to $92 million.
TPI Composites expects to price more than 7 million shares in the range of $15 to $17 per share for an initial public offering valued up to more than $141 million.
First Hawaiian has filed an S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). No pricing details were listed in the filing, but the offering is valued up to…
Forterra has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
CBS Radio has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Alcoa is scheduled to report its second-quarter financial results after the markets close on Monday.
24/7 Wall St. has put together a preview of Alcoa, Citigroup and some other major companies reporting their quarterly results this week.
24/7 Wall Street has picked out a few companies posting the largest losses last week, including Humana.
When PepsiCo reported second-quarter 2016 results on Thursday, overall the response was fairly positive.
Juno Therapeutics saw its shares sink on Friday after the U.S. Food and Drug Administration levied a clinical hold on its leukemia treatment.
WD-40 reported better-than-expected fiscal third-quarter financial results after the markets closed on Thursday.
PriceSmart reported mixed fiscal third-quarter financial results after the markets closed on Thursday.
Siris Capital Group submitted an offer to Polycom to acquire all outstanding shares, conditioned on Polycom terminating its existing merger agreement with Mitel Network.
Oppenheimer reiterated a Perform rating on Apple as well as its cautious view of the iPhone 7.
Juno Therapeutics saw its shares sink early on Friday after the U.S. Food and Drug Administration (FDA) levied a clinical hold on its leukemia treatment.
Shares of Eleven Biotherapeutics saw a handy gain early on Friday after the company announced that its Investigational New Drug application for EBI-031 has become effective.
